Trials / Unknown
UnknownNCT04416425
Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment
Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment: A Serial Follow-Up Study by Computed Tomography-Derived Fractional Flow Reserve
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Zibo Central Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Compelling evidences indicate that lipid-lowering therapy can reduce the high-risk plaque feathers and improve the coronary flow reserve. This study is going to investigate the change of lesion-specific hemodynamic significance as determined by ML(Machine Learning)-based CT-FFR (Computed Tomography-Fractional Flow Reserve)after Evolocumab treatment.
Conditions
Timeline
- Start date
- 2021-07-30
- Primary completion
- 2022-12-31
- Completion
- 2023-02-27
- First posted
- 2020-06-04
- Last updated
- 2021-04-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04416425. Inclusion in this directory is not an endorsement.